Verzenio was approved for a similar adjuvant indication last year, having been used for a couple of years only in patients ...

A patient with metastatic breast cancer confronts financial toxicity and finds a little glimmer of hope through donating ...

Giredestrant has a stronger anti-proliferative effect than anastrozole in patients with estrogen receptor-positive, HER2-negative, previously untreated early breast cancer, a new study suggests.

Ruscetti's previous research demonstrated that two cancer drugs (MEK inhibitor trametinib and CDK4/6 inhibitor palbociclib, or T/P) can promote blood vessel development, enabling greater T cell ...

The actress, who is being treated at Vanderbilt’s Breast Center in Nashville, is more than a week into taking Palbociclib, a drug that specifically targets breast cancer by blocking proteins that ...

Costa Rica stands among the healthiest countries in Latin America. The country is home to one of the five original Blue Zones ...

Palbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children's Oncology Group ...

Pancreatic ductal adenocarcinoma is the most common type of pancreatic cancer, with a low five-year survival rate of 13%. It is the third largest cause of cancer death. The microenvironment around ...